U.S. Markets closed

Novogen Limited (NVGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.88+0.03 (+4.09%)
At close: 4:00PM EDT
People also watch
Interactive chart
Previous Close0.85
Bid0.00 x
Ask1.79 x 8000
Day's Range0.85 - 0.89
52 Week Range0.85 - 2.44
Avg. Volume42,976
Market Cap15.72M
PE Ratio (TTM)-1.69
EPS (TTM)-0.52
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.73
Trade prices are not sourced from all markets
  • Yahoo Finance2 months ago

    Democrats found a way to speak Trump's language in pharma debate

    The members of congress introduced a bill related to the talk last week. A quartet of Democratic members of Congress introduced a bill last week in harmony with President Donald Trump’s campaign promises of lowering prescription drug costs. Entitled the Improving Access to Affordable Prescription Drugs Act, the 128-page bill aims to overhaul what many view as a broken system that has seen bipartisan outrage over skyrocketing prices.

  • Benzinga2 months ago

    Novogen Receives $4.4M R&D Tax Rebate

    Novogen Ltd (NASDAQ: NVGN ) is pleased to confirm receipt of $4.4m from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30 June 2016. These funds will be ...

  • PR Newswire3 months ago

    Transformation to a Clinical Stage Organisation Leads to Changes in Management Structure

    - Recent in-licensing of GDC-0084 and advancement of Cantrixil to phase I represent transformation of Novogen to clinical-stage organisation; recent appointments of Chief Medical Officer and Head of CMC ...